The Sanford Guide to Antimicrobial Therapy 2019

4.375 x 6.5 inches (Pocket Edition, approximate 5.5pt font). The 49th edition of the leading clinical reference on treatment of infectious diseases and anti-infective drug information. Helpful in day-to-day practice and as a component of your organization's antimicrobial stewardship program, the Sanford Guide provides valuable guidance in the age of antibiotic resistance. Popular with physicians, pharmacists, physician assistants, nurse practitioners, and others, the Sanford Guide to Antimicrobial Therapy provides information that is convenient, concise, and reliable. New in 2019: Table 1: osteomyelitis, mastitis, brain abscess, encephalitis, meningitis, otitis media, keratitis, gastroenteritis, urethritis, syphilis, pyelonephritis, vaginosis, endocarditis, prosthetic joint, UTIs, pneumonia (esp. GNB), pancreatitis, peritonitis, bites, burns, cellulitis, Lyme, febrile syndromes, sepsis, shock, botulism, IV lines/catheters, vascular Table 2: resistant bacteria, including GNB Table 3: duration of therapy Table 4: organism coverage expanded, drugs added (new and old) Table 5B: updated treatment options for GNB Table 6: updated recommendations for management of MRSA Table 8: pregnancy risk for new drugs Table 9: PK & interactions data for new drugs added Table 10: dosing updated and recent drugs added, e.g., plazomicin, eravacycline, omadacycline, temocillin, secnidazole Table 11: cryptococcosis Table 12: latent TB, MAC, M. abscessus Table 13: malaria, tafenoquine Table 14A: hemorrhagic fevers, influenza Table 14B: new HCV, CMV drugs Table 14C: new ARV drugs & combinations, updated recommended ART regimens Table 14F: updated HCV treatment regimens and recommendations Table 15: post-exposure prophylaxis Table 16: added peds dosing for additional antibacterials, ARVs, antivirals Table 17: renal adjustments for new drugs added Table 17C: updated obesity dose adjustments Table 22: DDIs reworked to focus on effects and suggested management